Amanote Research
Register
Sign In
Kronik Miyeloproliferatif Hastalık Olgularında JAK2 V617F Mutasyon Sıklığı
Harran Üniversitesi Tıp Fakültesi Dergisi
doi 10.35440/hutfd.645383
Full Text
Open PDF
Abstract
Available in
full text
Date
December 25, 2019
Authors
Özlem Öz
Publisher
Harran Universitesi Tip Fakultesi Dergisi
Related search
JAK2-V617F-mediated Signalling Is Dependent on Lipid Rafts and Statins Inhibit JAK2-V617F-dependent Cell Growth
British Journal of Haematology
Hematology
JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma
Indian Journal of Hematology and Blood Transfusion
Hematology
Screening of JAK2 V617F Mutation in Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Kronik Venöz Hastalık Tanısı Alan Sağlık Çalışanlarının CIVIQ-20 Anketiyle Değerlendirilmesi
Namık Kemal Tıp Dergisi
Evaluation on Thrombotic Events Frequency in JAK2 V617F Positive Patients
Journal of Hematology & Thromboembolic Diseases
Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms
Leukemia Research
Cancer Research
Oncology
Hematology
Kinetic Study of Human Full-Length Wild-Type JAK2 and V617F Mutant Proteins
The Open Enzyme Inhibition Journal
Sensitive PCR-based Monitoring and Early Detection of Relapsed JAK2 V617F Myelofibrosis Following Transplantation
British Journal of Haematology
Hematology
